Intellectual Property India Publishes Patent Application for 'Brucellosis Cell Immune Protein And Use Thereof' Filed by Tecon Biopharmaceutical Co. Ltd.

MUMBAI, India, Jan. 31 -- Intellectual Property India has published a patent application (202417084577 A) filed by Tecon Biopharmaceutical Co. Ltd., Xinjiang, China, on Nov. 5, 2024, for 'brucellosis cell immune protein and use thereof.'

Inventor(s) include He, Sun; and He, Chuanyu.

The application for the patent was published on Jan. 31, under issue no. 05/2025.

According to the abstract released by the Intellectual Property India: "Provided are a Brucellosis cell immune protein and the use thereof. In the present invention, firstly, a Brucella protein with relatively high immunogenicity is screened by means of antibody spectrum technology; then, the protein gene sequence of Brucella and the T cell epitope and antigen gene sequence of B...